Denise K Nawrocki

Title: Profile of Inventor Denise K Nawrocki

Introduction

Denise K Nawrocki is an accomplished inventor based in Annandale, NJ, known for her contributions in the field of biotechnology. She holds four patents, primarily focused on innovations related to human proprotein convertase subtilisin-kexin type 9 (PCSK9). Her work has significant implications for the treatment of conditions associated with PCSK9 activity.

Latest Patents

Denise's latest patents include the invention of PCSK9 antagonists. The patent numbered 1B20 describes these antagonists as effective agents for inhibiting PCSK9 function, which can be vital in treating related health conditions. The invention also includes nucleic acid encoding these antagonists, as well as methods for generating PCSK9-specific antagonists and their applications in medical treatments. Similarly, patent 1D05 covers related PCSK9 antagonists with similar functionalities and applications, further emphasizing her innovative efforts in this domain.

Career Highlights

Denise has made significant strides in her career, working with prestigious organizations such as Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. Her expertise in biotechnology and pharmaceutical innovations has enabled her to contribute meaningfully to her field.

Collaborations

Throughout her career, Denise has collaborated with notable colleagues, including Jon H Condra and Rose M Cubbon. These partnerships have played a crucial role in advancing her research and inventions, showcasing the importance of teamwork in the innovation process.

Conclusion

Denise K Nawrocki stands out as a remarkable inventor whose work on PCSK9 antagonists is paving the way for advancements in the treatment of related medical conditions. Her patents and collaborations reflect her commitment to innovation and her impact within the biotechnology industry.